New England Biolabs' NEBNext® Oligo Modules Offer Flexible Construction of Singleplex and Multiplex Libraries for the Illumina® Sequencing Platform

IPSWICH, Mass., Feb. 16, 2012 /PRNewswire/ -- New England Biolabs (NEB) today introduces NEBNext® Oligo Modules that enable the construction of singleplex or multiplex high yield libraries for DNA, ChIP-Seq or mRNA sequencing on Illumina® instruments. NEBNext Oligo Modules contain a novel adaptor that ligates efficiently to end-repaired, dA-tailed DNA.

(Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b )

Designed for maximum flexibility, two NEBNext Oligo Modules are now available: the NEBNext Multiplex Oligos Module includes the adaptor and 12 barcode PCR primers; the NEBNext Singleplex Oligos Module includes the adaptor and primers for singleplex library preparation, and is also compatible with custom barcode PCR primers. Both NEBNext Oligo Modules are compatible with standard library preparation protocols and reagents, including the NEBNext sets and modules for DNA, ChIP-Seq and mRNA. 

NEBNext products are a series of highly pure and cost-effective reagents that facilitate DNA and RNA library preparation for downstream applications, such as next generation sequencing. All reagents undergo stringent quality controls and functional validation by sequencing, ensuring maximum yield, convenience and value.

The NEBNext Oligo Modules are being introduced at the 2012 Advances in Genome Biology and Technology (AGBT) meeting, which is taking place February 15-18th, in Marco Island, Florida.

For more information, visit http://www.NEBNext.com

About New England Biolabs

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com.

NEBNext is a registered trademark of New England Biolabs, Inc.

Illumina is a registered trademark of Illumina, Inc.

SOURCE New England Biolabs

RELATED LINKS
http://www.neb.com